Published Studies Related to Isopto Cetamide (Sulfacetamide Ophthalmic)
Well-designed clinical trials related to Isopto Cetamide (Sulfacetamide Ophthalmic)
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. [2005.06]
Well-designed clinical trials possibly related to Isopto Cetamide (Sulfacetamide Ophthalmic)
Pilot investigation of the hydrating effects of topical acne medications. [2007.08]
Other research related to Isopto Cetamide (Sulfacetamide Ophthalmic)
The multifunctionality of 10% sodium sulfacetamide, 5% sulfur emollient foam in the treatment of inflammatory facial dermatoses. [2010.03]
Sulfacetamide loaded Eudragit(R) RL100 nanosuspension with potential for ocular delivery. [2010]
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. [2009.09]
Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model. [2009.08]
Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam. [2009.03]
Other possibly related research studies
Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption. [2006.04]
Topical therapies for rosacea. [2006.01]
Resistant scalp folliculitis secondary to Demodex infestation. [2005.11]
Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia. [2005.09]
Topical metronidazole combination therapy in the clinical management of rosacea. [2005.07]
Diagnosing and managing the patient with rosacea. [2005.04]
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. [2005.03]
Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence. [2008.02]
Antimicrobial prescribing trends in primary care: implications for health policy in Bahrain. [2008.04]
Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. [2007]
Effective over-the-counter acne treatments. [2008.09]
Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. [2008]
The cost-effectiveness of rosacea treatments. [2009]
[Rosacea: pathogenesis, clinical forms and therapy] [2010.07.25]
Rosacea: a review of current topical, systemic and light-based therapies. [2009.12]
Updates on the pathophysiology and management of acne rosacea. [2009.09]
Comparison of the Efficacy of Topical N-Acetyl-Cysteine and a Topical Steroid-Antibiotic Combination Therapy in the Treatment of Meibomian Gland Dysfunction. [2011.07.13]
Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance. [2011.06]
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. [2010.11]
Changes in rosacea comorbidities and treatment utilization over time. [2010.11]
Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. [2011.10]
Interventions for rosacea. [2011.03.16]
Effective and evidence-based management strategies for rosacea: summary of a
Cochrane systematic review. [2011]
Interventions for rosacea. [2011]
|
